Standard Chemical Pharmaceutical Co., Ltd. Announces 2025 Q4 Earnings Per Share of NT$5.19
NQ Score
55/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Standard Chemical Pharmaceutical Co., Ltd. (Stock Code: 1720) announced its financial report for the fourth quarter of 2025. The company's operating revenue for the quarter was NT$7.023 billion, with a net profit after tax of NT$1.256 billion, and basic earnings per share of NT$5.19. The company belongs to the biotechnology and medical industry.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What was Standard Chemical Pharmaceutical's operating revenue in Q4 2025?
- A: Standard Chemical Pharmaceutical's operating revenue in Q4 2025 was NT$7.023 billion.
- Q: What was the net profit after tax for Standard Chemical Pharmaceutical in Q4 2025?
- A: The net profit after tax for Standard Chemical Pharmaceutical in Q4 2025 was NT$1.256 billion.
- Q: What were the basic earnings per share for Standard Chemical Pharmaceutical in Q4 2025?
- A: The basic earnings per share for Standard Chemical Pharmaceutical in Q4 2025 were NT$5.19.
- Q: What industry does Standard Chemical Pharmaceutical belong to?
- A: Standard Chemical Pharmaceutical belongs to the biotechnology and medical industry.